ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.881,63
-0,43%
Dow Jones
42.544,22
-0,07%
Euro vs US Dollar
1,03517
0,02%
Bitcoin
94.352,87
-0,04%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Maxcyte Inc (MXCT) Börsenkurse

Maxcyte Inc

Maxcyte Inc (MXCT)

MaxCyte Inc
324,00
10,00
(3,18%)
Geschlossen 02 Januar 5:30PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
324,00
Gebot
320,00
Fragen
328,00
Volumen
4.251
317,00 Tagesbereich 324,00
256,00 52-Wochen-Bereich 420,00
Marktkapitalisierung
335,355M
Handelsende
314,00
Handelsbeginn
324,00
Letzte Trade
4250
@
321.2
(O)
Letzter Handelszeitpunkt
Finanzvolumen
13.348p
VWAP
314,00
Durchschnittliches Volumen (3 Mio.)
41.258
Ausgegebene Aktien
103.504.571
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-11,38
Gewinn pro Aktie (EPS)
-0,37
Erlöse
41,29M
Nettogewinn
-37,92M

Über Maxcyte Inc

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.maxcyte.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Maxcyte Inc is listed in the Biological Pds,ex Diagnstics sector of the Londoner Börse with ticker MXCT. The last closing price for Maxcyte was 314,00p. Over the last year, Maxcyte shares have traded in a share price range of 256,00p to 420,00p.

Maxcyte currently has 103.504.571 shares in issue. The market capitalisation of Maxcyte is £325,00 million. Maxcyte has a price to earnings ratio (PE ratio) of -11.38.

MXCT Neueste Nachrichten

Weitere Nachrichten

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. 31 December 2024     MaxCyte, Inc. ("MaxCyte" or the "Company")   Exercise of options and PDMR dealing   ROCKVILLE, MD, December 31, 2024: MaxCyte Inc., (NASDAQ: MXCT; LSE:...

31 Dezember 2024
RNS Regulatory News

MaxCyte, Inc. MaxCyte Announces Retirement of Board Member

MaxCyte, Inc. 23 December 2024     MaxCyte Announces Retirement of Board Member Art Mandell   ROCKVILLE, MD, December 23, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading...

23 Dezember 2024
RNS Regulatory News

MaxCyte Announces Retirement of Board Member Art Mandell

ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...

23 Dezember 2024
GlobeNewswire Inc.

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 19 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

19 Dezember 2024
RNS Regulatory News

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 18 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

18 Dezember 2024
RNS Regulatory News

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

10 Dezember 2024
RNS Regulatory News

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

10 Dezember 2024
RNS Regulatory News

MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings

MaxCyte Inc on Monday said the current year has been good for the company as it upgraded its core revenue guidance fo ...

09 Dezember 2024
Alliance News

MaxCyte, Inc. MaxCyte Streamlines Operations and Raises Guidance

MaxCyte, Inc. 09 December 2024     MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance   ROCKVILLE, MD, December 9, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a...

09 Dezember 2024
RNS Regulatory News

MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

ROCKVILLE, Md., Dec. 08, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the...

09 Dezember 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-3-0.9174311926613273403143100325.01386948DE
44716.967509025327734627626455306.51993238DE
123712.891986062728734625641258283.0210913DE
2641.2532038025625310290.26642186DE
52-28.5-8.08510638298352.542025628239333.28821796DE
156-426-56.8750785172.538405401.87479576DE
260200.5162.348178138123.5123012084423571.21422825DE

MXCT - Frequently Asked Questions (FAQ)

What is the current Maxcyte share price?
The current share price of Maxcyte is 324,00p
How many Maxcyte shares are in issue?
Maxcyte has 103.504.571 shares in issue
What is the market cap of Maxcyte?
The market capitalisation of Maxcyte is GBP 325M
What is the 1 year trading range for Maxcyte share price?
Maxcyte has traded in the range of 256,00p to 420,00p during the past year
What is the PE ratio of Maxcyte?
The price to earnings ratio of Maxcyte is -11,38
What is the cash to sales ratio of Maxcyte?
The cash to sales ratio of Maxcyte is 10,45
What is the reporting currency for Maxcyte?
Maxcyte reports financial results in USD
What is the latest annual turnover for Maxcyte?
The latest annual turnover of Maxcyte is USD 41,29M
What is the latest annual profit for Maxcyte?
The latest annual profit of Maxcyte is USD -37,92M
What is the registered address of Maxcyte?
The registered address for Maxcyte is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Maxcyte website address?
The website address for Maxcyte is www.maxcyte.com
Which industry sector does Maxcyte operate in?
Maxcyte operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VALValirx Plc
0,775p
(24,00%)
133,41M
TRAFTrafalgar Property Group Plc
0,03p
(20,00%)
7,96M
KODKodal Minerals Plc
0,455p
(12,35%)
76,26M
SCESurface Transforms Plc
0,46p
(12,20%)
17,27M
ZEDZenova Group Plc
0,75p
(11,11%)
1,39M
DGIDg Innovate Plc
0,0225p
(-70,39%)
809,27M
ADMEAdm Energy Plc
0,25p
(-41,18%)
3,39M
CLCOCloudcoco Group Plc
0,175p
(-22,22%)
3,05M
KLSOKelso Group Holdings Plc
2,60p
(-16,13%)
6,14M
WEBWebis Holdings Plc
0,055p
(-15,38%)
1,35M
DGIDg Innovate Plc
0,0225p
(-70,39%)
809,27M
NTVONativo Resources Plc
0,0019p
(-5,00%)
503,63M
TRPTower Resources Plc
0,036p
(-2,70%)
210,92M
SYMESupply@me Capital Plc
0,0035p
(-11,39%)
168,54M
PREMPremier African Minerals Limited
0,04p
(-9,09%)
158M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
MXCT
Maxcyte
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten